Arrowhead Pharmaceuticals, Inc. ARWR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

2/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Arrowhead Pharmaceuticals, Inc. (ARWR), incluyendo 13 compras y 33 ventas. El total de compras internas fue valorado en $963.33K y el total de ventas internas en $12.5M.

Internos destacados con actividad reciente incluyen Hamilton James C, O'brien Patrick, Apel Daniel Joseph. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — ARWR

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-03-05	Hamilton James C	Chief Medical Officer	Venta Informativa	10,000	$64.19	$641.9K	236,958
2026-01-06	O'brien Patrick	COO	Donación (Otorgada)	440	-	-	472,408
2026-01-06	Hamilton James C	Chief Medical Officer	Concesión de RSU	75,000	-	-	246,958
2026-01-06	Apel Daniel Joseph	Chief Financial Officer	Concesión de RSU	75,000	-	-	176,200
2026-01-05	O'brien Patrick	COO	Venta Informativa	46	$68.00	$3.13K	474,908
2026-01-05	Hamilton James C	Chief Medical Officer	Venta Informativa	309	$68.00	$21.01K	171,958
2026-01-02	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	5,771	$66.39	$383.14K	3,792,739
2025-12-31	O'brien Patrick	COO	Donación (Otorgada)	560	-	-	524,401
2025-12-29	Anzalone Christopher Richard	Chief Executive Officer	Ejercicio de Opciones (Venta)	16,545	$6.15	$101.75K	-
2025-12-26	Ferrari Mauro	Director	Venta Informativa	7,530	$70.00	$527.1K	69,053
2025-12-22	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	2,574	$68.85	$177.22K	3,805,926
2025-12-19	Olukotun Adeoye Y	Director	Venta Informativa	827	$68.48	$56.63K	33,600
2025-12-19	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	1,319	$68.48	$90.33K	3,818,512
2025-12-19	Waddill William D.	Director	Venta Informativa	500	$68.53	$34.27K	56,563
2025-12-19	Vakiener Victoria	Director	Venta Informativa	1,960	$68.39	$134.04K	35,723
2025-12-17	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	1,981	$66.30	$131.34K	3,831,957
2025-12-16	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	3,221	$67.87	$218.61K	3,916,957
2025-12-16	Ingram Douglas S	Director	Concesión de RSU	7,819	-	-	46,215
2025-12-16	Olukotun Adeoye Y	Director	Concesión de RSU	7,819	-	-	43,600
2025-12-16	Perry Michael S	Director	Concesión de RSU	7,819	-	-	123,059
2025-12-16	Ferrari Mauro	Director	Concesión de RSU	7,819	-	-	76,583
2025-12-16	Waddill William D.	Director	Concesión de RSU	7,819	-	-	64,930
2025-12-16	Lu Hongbo	Director	Concesión de RSU	7,819	-	-	54,982
2025-12-16	Vakiener Victoria	Director	Concesión de RSU	7,819	-	-	45,763
2025-12-15	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	8,147	$69.96	$569.96K	3,971,255
2025-12-12	Anzalone Christopher Richard	Chief Executive Officer	Concesión de RSU	180,000	-	-	4,101,255
2025-12-05	Perry Michael S	Director	Venta Informativa	16,250	$61.03	$991.74K	115,240
2025-11-28	Ferrari Mauro	Director	Venta Informativa	8,750	$56.39	$493.41K	68,764
2025-10-01	Hamilton James C	Chief Medical Officer	Venta Informativa	20,000	$35.00	$700K	212,122
2025-09-12	Hamilton James C	Chief Medical Officer	Venta Informativa	15,000	$30.00	$450K	232,122
2025-09-02	Hamilton James C	Chief Medical Officer	Venta Informativa	15,000	$25.00	$375K	247,122
2025-08-15	Hamilton James C	Chief Medical Officer	Venta Informativa	9,389	$20.00	$187.78K	262,122
2025-08-13	Hamilton James C	Chief Medical Officer	Venta Informativa	611	$20.00	$12.22K	271,511
2025-04-15	Apel Daniel Joseph	Chief Financial Officer	Desconocido	-	-	-	101,200
2025-04-11	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	50,800	$11.49	$583.69K	3,921,255
2025-04-10	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	50,000	$10.87	$543.5K	3,972,055
2025-04-09	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	1,617	$11.76	$19.02K	4,022,055
2025-03-13	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	51,425	$15.07	$774.97K	4,062,377
2025-03-04	Anzalone Christopher Richard	Chief Executive Officer	Venta Informativa	133,333	$17.02	$2.27M	3,773,802
2025-03-03	Anzalone Christopher Richard	Chief Executive Officer	Ejercicio de Opciones (Venta)	133,333	$7.75	$1.03M	51,726
2025-02-07	Anzalone Christopher Richard	Chief Executive Officer	Concesión de RSU	9,550	$20.10	$191.96K	3,773,802
2025-02-06	Ingram Douglas S	Director	Desconocido	-	-	-	-
2025-02-06	Ingram Douglas S	Director	Concesión de RSU	38,396	$20.09	$771.38K	38,396
2025-01-23	Olukotun Adeoye Y	Director	Venta Informativa	959	$21.00	$20.14K	35,781
2025-01-07	Myszkowski Kenneth Allen	Chief Financial Officer	Venta Informativa	10,000	$19.69	$196.9K	455,433
2025-01-07	O'brien Patrick	COO and General Counsel	Venta Informativa	8,000	$19.69	$157.52K	527,201
2025-01-06	Myszkowski Kenneth Allen	Chief Financial Officer	Venta Informativa	9,402	$20.10	$188.98K	473,433
2025-01-06	O'brien Patrick	COO and General Counsel	Venta Informativa	9,526	$20.10	$191.47K	535,201
2025-01-06	Hamilton James C	Chief Discovery/trans Medicine	Venta Informativa	10,971	$20.11	$220.63K	272,122
2025-01-04	Myszkowski Kenneth Allen	Chief Financial Officer	Concesión de RSU	100,000	-	-	500,600

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento